跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML
Approved
THERAPEUTIC
MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML
Fresenius Kabi Poland Sp. z.o.o
🇸🇬 Health Sciences Authority
Approval Date
Jul 31, 2017
Approval ID
e1a6d59051b22e62
Company
Fresenius Kabi Poland Sp. z.o.o
Type
Therapeutic
Approval Details
Approval Id
e1a6d59051b22e62
Drug Name
MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML
Product Name
MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML
Approval Number
SIN15310P
Approval Date
2017-07-31
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01MA14
Atc Item Name
moxifloxacin
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Moxifloxacin Hydrochloride 437.5mg/250ml eqv Moxifloxacin
400mg/250ml
MOXIFLOXACIN HYDROCHLORIDE 437.5 MG/250 ML EQV MOXIFLOXACIN
400 MG/250 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 31, 2017
Approval ID
e1a6d59051b22e62
Type
Therapeutic
Back to HSA Approvals
MOXIFLOXACIN KABI SOLUTION FOR INFUSION 400MG/250ML - HSA Drug Approval Details
